US 7326713
Substituted tricyclic compound as protein kinase inhibitors
granted A61PA61P35/00A61P35/04
Quick answer
US patent 7326713 (Substituted tricyclic compound as protein kinase inhibitors) held by Arizona Board of Regents on Behalf of the University of Arizona expires Mon Jan 31 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Arizona Board of Regents on Behalf of the University of Arizona
- Grant date
- Tue Feb 05 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 31 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61P, A61P35/00, A61P35/04, A61P43/00